India’s Vaccine Regulatory System Declared Functional by WHO

India’s vaccine regulatory system has been recognized as “functional” by the World Health Organization (WHO) following an evaluation from September 16-20, 2024. The WHO assessment team confirmed that India meets global standards for ensuring vaccine safety, quality, and efficacy. This recognition reaffirms India’s significant role in the global pharmaceutical industry, especially in vaccine production, while showcasing its regulatory strength through Maturity Level 3 certification in the WHO Global Benchmarking Tool.

WHO Evaluation Overview

The WHO team evaluated key areas such as registration, licensing, market surveillance, regulatory inspections, and clinical trial oversight. India’s National Regulatory Authority (NRA), led by the Central Drugs Standard Control Organisation (CDSCO), was found to meet the required standards for a well-functioning vaccine regulatory system. The WHO Prequalification Programme underscores the importance of a robust NRA for global vaccine distribution.

Continuous Improvement and Global Role

While India’s regulatory system has reached a high benchmark, the WHO team has proposed an Institutional Development Plan for further enhancement. Union Health Secretary Punya Salila Srivastava, WHO Representative Dr. Roderico H. Ofrin, and Drugs Controller General Dr. Rajeev Singh Raghuvanshi highlighted India’s leadership in supplying vaccines globally, reaffirming its commitment to maintaining the highest standards in vaccine production and regulation.

WHO Recognition of India’s Vaccine Regulatory System

Why in News Key Points
WHO Recognition India’s vaccine regulatory system recognized as “functional” by WHO after an evaluation in September 2024.
WHO Evaluation Overview Evaluation covered registration, licensing, market surveillance, inspections, and clinical trials. India’s National Regulatory Authority (NRA), led by CDSCO, meets global standards.
Continuous Improvement and Global Role WHO proposed an Institutional Development Plan for further enhancement. India’s leadership in global vaccine supply reaffirmed.

Piyush Shukla

Recent Posts

S-500 Missile System: Features, Range, Speed, Comparison and India’s Interest

Russia’s S-500 Missile System, officially known as 55R6M “Triumfator-M” or Prometey, is shaping the future…

6 mins ago

RELOS Agreement and India–Russia Relations: Objectives, Significance & Latest Developments

India–Russia relations continue to evolve in a changing global order. Ahead of President Vladimir Putin’s…

14 mins ago

Which City is Known as the Science City of India? Know About It

India has many cities known for their unique identity, and some of them are famous…

45 mins ago

Fitch Ups India’s FY26 Growth Forecast to 7.4% Amid Strong Consumer Demand

Global credit rating agency Fitch Ratings has revised India’s GDP growth forecast for FY26 to…

58 mins ago

Asim Munir Formally Appointed Pakistan’s First Chief of Defence Forces

In a landmark shift in Pakistan’s military command structure, Field Marshal Asim Munir has been…

60 mins ago

Top 10 States with Smart City Projects in India (2025 Update)

India’s Smart Cities Mission (SCM), launched in 2015, is entering its final stretch with an…

2 hours ago